New Sunshine Rules In The EU, And How They Compare To US Requirements
Two EU member states are introducing new sunshine rules to boost transparency. Is the EU following the US lead? Attorneys Hein van den Bos and Ron Wisor discuss EU trends and US burdens.
You may also be interested in...
As CMS releases its 2015 "Open Payments" data on device and drug company payments to physicians, the agency is citing improvements in search tools and usability of the data. But one small startup device firm described onerous and inefficient reporting requirements, and the American Medical Association is citing "registration challenges" and continued data errors on the physician end.
The Centers for Medicare and Medicaid Services hasn’t yet cracked down on missing Open Payments submissions, although the agency has financial penalties at its disposal, speakers said during a recent Food and Drug Law Institute webinar. Meanwhile, companies continue to face challenges in maintaining compliance to both federal and state payment disclosure requirements.
Device firm representatives were pleased, at least on first review, with CMS’ presentation of the industry-submitted physician payment data posted online for the first time Sept. 30, including the public context provided for the database.